切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (02) : 74 -78. doi: 10.3877/cma.j.issn.2095-3232.2014.02.003

所属专题: 文献

临床研究

肝细胞癌破裂亚临床出血患者择期肝切除术后的生存预后分析
孔杰1, 吴力群1,()   
  1. 1. 266003 青岛大学医学院附属医院肝胆外科
  • 收稿日期:2014-01-13 出版日期:2014-04-10
  • 通信作者: 吴力群

Survival and prognostic analysis of ruptured hepatocellular carcinoma patients with subclinical bleeding after elective hepatectomy

Jie Kong1, Liqun Wu1,()   

  1. 1. Department of Hepatobiliary Surgery, the Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China
  • Received:2014-01-13 Published:2014-04-10
  • Corresponding author: Liqun Wu
  • About author:
    Corresponding author: Wu Liqun, Email:
引用本文:

孔杰, 吴力群. 肝细胞癌破裂亚临床出血患者择期肝切除术后的生存预后分析[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(02): 74-78.

Jie Kong, Liqun Wu. Survival and prognostic analysis of ruptured hepatocellular carcinoma patients with subclinical bleeding after elective hepatectomy[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(02): 74-78.

目的

探讨肝细胞癌(肝癌)破裂亚临床出血患者择期肝切除术后的预后。

方法

回顾性分析1997年1月至2010年12月在青岛大学医学院附属医院肝胆外科行择期肝切除术的614例肝癌患者临床资料。所有患者均签署知情同意书,符合医学伦理学规定。根据有否出现肝癌破裂亚临床出血,将患者分为破裂组和非破裂组。其中破裂组30例,男25例,女5例,年龄29~73岁,中位年龄55岁;非破裂组584例,男488例,女96例,年龄14~82岁,中位年龄55岁。所有患者均行肝切除术。观察破裂组与非破裂组患者的临床特征。患者术后均接受随访,观察患者存活情况、死亡原因。根据随访结果绘制Kaplan-Meier生存曲线,比较两组患者的存活情况。分析临床参数与破裂组患者预后的关系。两组临床参数比较采用χ2检验或Fisher确切概率法。组间多因素分析采用Logistic回归分析。生存分析和比较采用Kaplan-Meier法和Log-rank检验,预后危险因素分析采用Cox比例风险回归模型分析。

结果

破裂组中非完全切除、肝切除范围>1段、手术切缘<0.5 cm、术中输血、术中出血量≥1 000 ml、肿瘤直径>5 cm和肿瘤组织学低分化者明显多于非破裂组(χ2=37.609,6.021,6.497,20.982,19.498,22.944,8.222;P<0.05)。进一步Logistic回归分析显示,非完全切除和肿瘤直径>5 cm是肝癌破裂亚临床出血的独立危险因素(OR=3.772,5.045;P<0.05)。随访期间破裂组死亡26例,非破裂组死亡316例。Kaplan-Meier分析显示,破裂组的中位生存期为9个月,非破裂组为56个月;破裂组患者肝切除术后的1、3、5年累积生存率分别为50.0%、22.2%、5.9%,非破裂组为86.0%、62.6%、48.9%,差异有统计学意义(χ2=38.879,P<0.05)。Cox比例风险回归模型分析显示,肿瘤组织学低分化是破裂组患者肝切除术后预后的独立危险因素(RR=3.736,P<0.05)。

结论

非完全切除和肿瘤直径>5 cm是肝癌破裂亚临床出血的独立危险因素。肝癌破裂亚临床出血患者择期肝切除术后预后仍较差,肿瘤组织学低分化是影响其预后的独立危险因素。

Objective

To discuss the prognosis of ruptured hepatocellular carcinoma (HCC) patients with subclinical bleeding after elective hepatectomy.

Methods

Clinical data of 614 patients with HCC who underwent elective hepatectomy in Department of Hepatobiliary Surgery, the Affiliated Hospital of Medical College, Qingdao University from January 1997 to December 2010 were analyzed retrospectively. The informed consents of all patients were obtained and the ethical committee approval was received. According to whether the patients had subclinical bleeding following ruptured HCC or not, they were devided into ruptured group (n=30; 25 males, 5 females; 29 to 73 of age, 55 of median age) and non-ruptured group (n=584; 488 males, 96 females; 14 to 82 of age, 55 of median age). All the patients underwent hepatectomy. Clinical characters of patients in ruptured group and non-ruptured group were observed. All the patients received follow-up after operations, the survival and causes of death were observed. The Kaplan-Meier survival curves were drawn according to the results of follow-up, and the survival of 2 groups was compared. The relation between the clinical parameters and the prognosis of patients in ruptured group was analyzed. The clinical parameters in 2 groups were compared using Chi-square test or Fisher’s exact probability method. Multiple factors analysis between groups was conducted using Logistic regression analysis. Survival analysis and comparison were conducted using Kaplan-Meier method and Log-rank test. Prognostic risk factor analysis was conducted using Cox proportional hazards regression model analysis.

Results

The patients with non-radical resection, liver resection range > 1 segment, surgical margin < 0.5 cm, intraoperative transfusion, intraoperative blood loss ≥ 1 000 ml, tumor diameter > 5 cm and poorly differentiated tumor in ruptured group were significantly more than those in non-ruptured group (χ2=37.609, 6.021, 6.497, 20.982, 19.498, 22.944, 8.222; P<0.05). Further Logistic regression analysis showed that non-radical resection and tumor diameter > 5 cm were the independent risk factors for ruptured HCC with subclinical bleeding (OR=3.772, 5.045; P<0.05). There were 26 deaths in ruptured group and 316 deaths in non-ruptured group during the follow-up. Kaplan-Meier analysis showed that the median survival time was 9 months in ruptured group and 56 months in non-ruptured group. The 1-, 3-, 5-year accumulative survival rate were 50.0%, 22.2%, 5.9% in ruptured group and 86.0%, 62.6%, 48.9% in non-ruptured group respectively, where significant difference was observed (χ2=38.879, P<0.05). Cox proportional hazards regression model analysis showed that poorly differentiated tumor was an independent risk factor for patients in ruptured group after hepatectomy (RR=3.736, P<0.05).

Conclusions

Non-radical resection and tumor diameter > 5 cm are the independent risk factors for ruptured HCC with subclinical bleeding. The prognosis of ruptured HCC patients with subclinical bleeding after elective hepatectomy is still poor, and poorly differentiated tumor is an independent risk factor for it.

表1 破裂组与非破裂组患者临床参数的比较(例)
图1 破裂组与非破裂组患者肝切除术后Kaplan-Meier生存曲线
表2 破裂组患者肝切除术后预后的Cox比例风险回归模型分析结果
[1]
Bassi N,Caratozzolo E,Bonariol L, et al. Management of ruptured hepatocellular carcinoma: implications for therapy[J]. World J Gastroenterol, 2010, 16(10): 1221-1225.
[2]
Battula N,Madanur M,Priest O, et al. Spontaneous rupture of hepatocellular carcinoma: a Western experience[J]. Am J Surg, 2009, 197(2): 164-167.
[3]
Vergara V,Muratore A,Bouzari H, et al. Spontaneous rupture of hepatocelluar carcinoma: surgical resection and long-term survival[J]. Eur J Surg Oncol, 2000, 26(8): 770-772.
[4]
Zhu Q,Li J,Yan JJ, et al. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma[J]. World J Gastroenterol, 2012, 18(48): 7302-7307.
[5]
Kogut MJ,Bastawrous S,Padia S, et al. Hepatobiliary oncologic emergencies: imaging appearances and therapeutic options[J]. Curr Probl Diagn Radiol, 2013, 42(3): 113-126.
[6]
Chong CC,Lee KF,Ip PC, et al. Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: can we predict earlier?[J]. Surgeon, 2012, 10(5): 260-266.
[7]
Chen WK,Chang YT,Chung YT, et al. Outcomes of emergency treatment in ruptured hepatocellular carcinoma in the ED[J]. Am J Emerg Med, 2005, 23(6): 730-736.
[8]
Lin CC,Chen CH,Tsang YM, et al. Diffuse intraperitoneal metastasis after spontaneous rupture of hepatocellular carcinoma[J]. J Formos Med Assoc, 2006, 105(7): 577-582.
[9]
Rossetto A,Adani GL,Risaliti A, et al. Combined approach for spontaneous rupture of hepatocellular carcinoma[J]. World J Hepatol, 2010, 2(1): 49-51.
[10]
Kim JS,Yoon SK,Kim JA, et al. Long-term survival in a patient with ruptured hepatocellular carcinoma[J]. Korean J Intern Med, 2009, 24(1): 63-67.
[11]
Cucchetti A,Qiao G,Cescon M, et al. Anatomic versus non-anatomic resection in cirrhotic patients with early hepatocellular carcinoma[J]. Surgery, 2014,155(3):512-521.
[12]
Vauthey JN,Dixon E,Abdalla EK, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement[J]. HPB, 2010, 12(5): 289-299.
[13]
Zhou L,Rui JA,Wang SB, et al. Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade[J]. Eur J Surg Oncol, 2011, 37(6): 521-525.
[14]
Ono F,Hiraga M,Omura N, et al. Hemothorax caused by spontaneous rupture of hepatocellular carcinoma: a case report and review of the literature[J]. World J Surg Oncol, 2012(10): 215.
[15]
Llovet JM,Ricci S,Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma[J]. N Engl J Med, 2008, 359(4): 378-390.
[16]
Cheng AL,Kang YK,Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomised, double-blind, placebo-controlled trial[J]. Lancet Oncol, 2009, 10(1): 25-34.
[17]
吴力群,李子祥,梁军.索拉非尼联合手术或联合经导管肝动脉栓塞化疗治疗进展期肝癌的预后比较[J].肿瘤研究与临床, 2013, 25(8): 543-546.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[7] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[8] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[9] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[10] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[11] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?